Lv4
538 积分 2025-08-14 加入
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
2个月前
已完结
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
2个月前
已完结
1319-OR: Oral TIX100 Protects against Weight Rebound after Semaglutide Discontinuation
2个月前
已关闭
Urocortins and their unfolding role in mammalian social behavior
2个月前
已完结
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial
3个月前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
3个月前
已完结
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
3个月前
已完结
A structural basis for amylin receptor phenotype
5个月前
已完结
Amylin receptors as therapeutic targets in obesity: Emerging peptide-based strategies
5个月前
已完结
A new era in targeted sEH therapy: strategic evolution from inhibition to protein degradation
5个月前
已完结
皖公网安备34019202002308
